Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Oct;104(2):379–384. doi: 10.1111/j.1476-5381.1991.tb12439.x

Inhibition of the tocolytic activity of atrial natriuretic factor by progesterone and potentiation by progesterone receptor antagonist RU486 in rats.

W Potvin 1, S Mulay 1, D R Varma 1
PMCID: PMC1908542  PMID: 1839136

Abstract

1. The influence of progesterone on the activity of atrial natriuretic factor (ANF) on rat myometrial motor activity was determined in vitro. 2. ANF inhibited the tension development by myometrium from cycling or oestrogen-treated rats in a dose-dependent manner; maximal inhibition was 100%. 3. Injections of progesterone into rats inhibited the tocolytic activity of ANF in a dose and time-dependent manner. The tocolytic effects of ANF were completely abolished by 3 daily injections of 1 mg kg-1 progesterone. 4. Pregnancy-related increase in plasma progesterone was accompanied by a corresponding decrease in the tocolytic effects of ANF; myometria from gestational day 10 to 21 were completely refractory and those from earlier gestational age and immediate postpartum were responsive to ANF to varying degrees. 5. Treatment of pregnant rats with the progesterone antagonist, RU486, caused abortions and vaginal bleeding, decreased plasma progesterone concentrations and restored the tocolytic activity of ANF. Tocolytic activity of ANF on virgin rat myometria was potentiated by RU486. 6. Progesterone also inhibited the effects of ANF on myometria from ovariectomized rats. 7. Tocolytic activity of isoprenaline was not modified by progesterone, pregnancy, RU486 or ovariectomy. 8. It is concluded that progesterone antagonizes myometrial effects of ANF by an oestrogen-independent mechanism and the pregnancy-induced refractoriness to the tocolytic effects of ANF is caused by progesterone.

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baulieu E. E. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science. 1989 Sep 22;245(4924):1351–1357. doi: 10.1126/science.2781282. [DOI] [PubMed] [Google Scholar]
  2. Bek T., Ottesen B., Fahrenkrug J. The effect of galanin, CGRP and ANP on spontaneous smooth muscle activity of rat uterus. Peptides. 1988 May-Jun;9(3):497–500. doi: 10.1016/0196-9781(88)90154-4. [DOI] [PubMed] [Google Scholar]
  3. Brenner B. M., Ballermann B. J., Gunning M. E., Zeidel M. L. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 1990 Jul;70(3):665–699. doi: 10.1152/physrev.1990.70.3.665. [DOI] [PubMed] [Google Scholar]
  4. Butcher R. L., Collins W. E., Fugo N. W. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology. 1974 Jun;94(6):1704–1708. doi: 10.1210/endo-94-6-1704. [DOI] [PubMed] [Google Scholar]
  5. Castro L. C., Arora C., Parvez S., Parvez H., Valenzuela G., Hobel C. J. Plasma atrial natriuretic peptide levels during the rat estrous cycle, pregnancy, and puerperium. Am J Obstet Gynecol. 1989 Jan;160(1):15–19. doi: 10.1016/0002-9378(89)90078-1. [DOI] [PubMed] [Google Scholar]
  6. Chemtob S., Potvin W., Varma D. R. Selective increase in placental blood flow by atrial natriuretic peptide in hypertensive rats. Am J Obstet Gynecol. 1989 Feb;160(2):477–479. doi: 10.1016/0002-9378(89)90475-4. [DOI] [PubMed] [Google Scholar]
  7. Cheung C. Y., Gibbs D. M., Brace R. A. Atrial natriuretic factor in maternal and fetal sheep. Am J Physiol. 1987 Feb;252(2 Pt 1):E279–E282. doi: 10.1152/ajpendo.1987.252.2.E279. [DOI] [PubMed] [Google Scholar]
  8. Downing S. J., Porter D. G., Redstone C. D. Myometrial activity in rats during the oestrous cycle and pseudopregnancy: interaction of oestradiol and progesterone. J Physiol. 1981 Aug;317:425–433. doi: 10.1113/jphysiol.1981.sp013834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elias A. N., Vaziri N. D., Pandian M. R., Powers D. R., Domurat E. Atrial natriuretic peptide and arginine vasopressin in pregnancy and pregnancy-induced hypertension. Nephron. 1988;49(2):140–143. doi: 10.1159/000185040. [DOI] [PubMed] [Google Scholar]
  10. Granger S. E., Hollingsworth M., Weston A. H. A comparison of several calcium antagonists on uterine, vascular and cardiac muscles from the rat. Br J Pharmacol. 1985 May;85(1):255–262. doi: 10.1111/j.1476-5381.1985.tb08854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hatjis C. G., Greelish J. P., Kofinas A. D., Stroud A., Hashimoto K., Rose J. C. Atrial natriuretic factor maternal and fetal concentrations in severe preeclampsia. Am J Obstet Gynecol. 1989 Oct;161(4):1015–1019. doi: 10.1016/0002-9378(89)90776-x. [DOI] [PubMed] [Google Scholar]
  12. Hatjis C. G., Grogan D. M. Atrial natriuretic peptide receptors in normal human placentas. Am J Obstet Gynecol. 1988 Sep;159(3):587–591. doi: 10.1016/s0002-9378(88)80014-0. [DOI] [PubMed] [Google Scholar]
  13. Hatjis C. G., Grogan D. M. Changes in placental atrial natriuretic peptide receptors associated with severe toxemia of pregnancy. Placenta. 1989 Mar-Apr;10(2):153–159. doi: 10.1016/0143-4004(89)90037-4. [DOI] [PubMed] [Google Scholar]
  14. Kristensen C. G., Nakagawa Y., Coe F. L., Lindheimer M. D. Effect of atrial natriuretic factor in rat pregnancy. Am J Physiol. 1986 Apr;250(4 Pt 2):R589–R594. doi: 10.1152/ajpregu.1986.250.4.R589. [DOI] [PubMed] [Google Scholar]
  15. McQueen J., Kingdom J. C., Jardine A. G., Connell J. M., Whittle M. J. Vascular angiotensin II and atrial natriuretic peptide receptors in normal and growth-retarded human placentae. J Endocrinol. 1990 Aug;126(2):341–347. doi: 10.1677/joe.0.1260341. [DOI] [PubMed] [Google Scholar]
  16. Miyamoto S., Shimokawa H., Sumioki H., Nakano H. Physiologic role of endogenous human atrial natriuretic peptide in preeclamptic pregnancies. Am J Obstet Gynecol. 1989 Jan;160(1):155–159. doi: 10.1016/0002-9378(89)90110-5. [DOI] [PubMed] [Google Scholar]
  17. Morishige W. K., Pepe G. J., Rothchild I. Serum luteinizing hormone, prolactin and progesterone levels during pregnancy in the rat. Endocrinology. 1973 May;92(5):1527–1530. doi: 10.1210/endo-92-5-1527. [DOI] [PubMed] [Google Scholar]
  18. Mulay S., Varma D. R. Placental barrier to atrial natriuretic peptide in rats. Can J Physiol Pharmacol. 1989 Jan;67(1):1–4. doi: 10.1139/y89-001. [DOI] [PubMed] [Google Scholar]
  19. Mulay S., Varma D. R., Solomon S. Influence of protein deficiency in rats on hormonal status and cytoplasmic glucocorticoid receptors in maternal and fetal tissues. J Endocrinol. 1982 Oct;95(1):49–58. doi: 10.1677/joe.0.0950049. [DOI] [PubMed] [Google Scholar]
  20. Olsson K., Karlberg B. E., Eriksson L. Atrial natriuretic peptide in pregnant and lactating goats. Acta Endocrinol (Copenh) 1989 Apr;120(4):519–525. doi: 10.1530/acta.0.1200519. [DOI] [PubMed] [Google Scholar]
  21. Otsuki Y., Okamoto E., Iwata I., Nishino E., Mitsuda N., Mori M., Takagi T., Sugita N., Tanizawa O. Changes in concentration of human atrial natriuretic peptide in normal pregnancy and toxaemia. J Endocrinol. 1987 Aug;114(2):325–328. doi: 10.1677/joe.0.1140325. [DOI] [PubMed] [Google Scholar]
  22. Pelletier G. Localization of binding sites for ANF in the rat mammary gland. Peptides. 1988 May-Jun;9(3):673–675. doi: 10.1016/0196-9781(88)90181-7. [DOI] [PubMed] [Google Scholar]
  23. Potvin W., Varma D. R. Refractoriness of the gravid rat uterus to tocolytic and biochemical effects of atrial natriuretic peptide. Br J Pharmacol. 1990 Jun;100(2):341–347. doi: 10.1111/j.1476-5381.1990.tb15806.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rutherford A. J., Anderson J. V., Elder M. G., Bloom S. R. Release of atrial natriuretic peptide during pregnancy and immediate puerperium. Lancet. 1987 Apr 18;1(8538):928–929. doi: 10.1016/s0140-6736(87)92910-2. [DOI] [PubMed] [Google Scholar]
  25. Sen I. Identification and solubilization of atrial natriuretic factor receptors in human placenta. Biochem Biophys Res Commun. 1986 Mar 13;135(2):480–486. doi: 10.1016/0006-291x(86)90019-7. [DOI] [PubMed] [Google Scholar]
  26. Shaikh A. A. Estrone and estradiol levels in the ovarian venous blood from rats during the estrous cycle and pregnancy. Biol Reprod. 1971 Dec;5(3):297–307. doi: 10.1093/biolreprod/5.3.297. [DOI] [PubMed] [Google Scholar]
  27. St-Louis J., Parent A., Gutkowska J., Genest J., Schiffrin E. L. Vasorelaxation and vascular binding sites for atrial natriuretic peptide in pregnant rats. Am J Physiol. 1988 Jun;254(6 Pt 2):H1027–H1033. doi: 10.1152/ajpheart.1988.254.6.H1027. [DOI] [PubMed] [Google Scholar]
  28. Steegers E. A., Hein P. R., Tan A. C., Groeneveld E. A., Jongsma H. W., Benraad T. J. Plasma atrial natriuretic peptide (ANP) in late pregnancy and puerperium. Eur J Obstet Gynecol Reprod Biol. 1987 Nov;26(3):213–217. doi: 10.1016/0028-2243(87)90070-0. [DOI] [PubMed] [Google Scholar]
  29. Thomsen J. K., Storm T. L., Thamsborg G., de Nully M., Bødker B., Skouby S. Atrial natriuretic peptide concentrations in pre-eclampsia. Br Med J (Clin Res Ed) 1987 Jun 13;294(6586):1508–1510. doi: 10.1136/bmj.294.6586.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Törnell J., Carlsson B., Billig H. Atrial natriuretic peptide inhibits spontaneous rat oocyte maturation. Endocrinology. 1990 Mar;126(3):1504–1508. doi: 10.1210/endo-126-3-1504. [DOI] [PubMed] [Google Scholar]
  31. Varma D. R., Ramakrishnan R. A rat model for the study of transplacental pharmacokinetics and its assessment with antipyrine and aminoisobutyric acid. J Pharmacol Methods. 1985 Aug;14(1):61–74. doi: 10.1016/0160-5402(85)90043-9. [DOI] [PubMed] [Google Scholar]
  32. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES